Karin Ruth Holm

Karin Ruth Holm
École Polytechnique Fédérale de Lausanne | EPFL · Blue Brain Project (BBP)



How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
Karin Holm currently works as Science Writer at the Ecole polytechnique fédérale de Lausanne's (EPFL) Blue Brain Project, a Swiss-funded simulation neuroscience and supercomputing fundamental research initiative based in Geneva, Switzerland. Karin is also interested in patient involvement in research and improving clinical practice. Previously she worked in global public health and co-authored review articles and edited publications in pharmacovigilance.
Skills and Expertise
Additional affiliations
December 2017 - June 2022
École Polytechnique Fédérale de Lausanne
  • Science Writer
September 2015 - August 2017
Council for International Organizations of Medical Sciences (CIOMS)
  • Consultant
March 2013 - September 2015
Council for International Organizations of Medical Sciences (CIOMS)
  • Technical Collaboration Coordinator


Publications (5)
Objective The peer-led Cancer Thriving and Surviving Program (CTS) has demonstrated improved health outcomes for cancer survivors. We describe a co-creative process for adapting the CTS for breast cancer survivors in Switzerland and integrating the program into the clinical pathway of Swiss breast centers. Methods A co-creative approach was employ...
Global immunization efforts to date have heavily focused on infants and children, with noted success on public health. Healthy adolescents and adults contribute to the economic growth and development of countries but efforts to ensure vaccine coverage for these groups receive inadequate global attention and resources. Emerging epidemics for a numbe...
In 2013, the Council for International Organizations of Medical Sciences (CIOMS) created a Working Group on Vaccine Safety (WG) to address unmet needs in the area of vaccine pharmacovigilance. Generating reliable data about specific vaccine safety concerns is becoming a priority due to recent progress in the development and deployment of new vaccin...


Cited By


Projects (2)
The COSS pilot-study will include two Work Packages (WP). The first one (WP1) has an explorative design. Three workshops with health care professionals and breast cancer survivors will be conducted to co-create the CTS-BC-CH, which will be finalized in a consensus conference. In the second WP, the feasibility of the program and study design will be tested in a pilot study in two breast centers. Based on the findings from the pilot study, we will plan a randomized controlled trial to investigate the CTS-BC-CH effects on practices in self-management support.